Full Description
The Clinical Handbook of Psychotropic Drugs has become a
standard reference and working tool for psychiatrists, psychologists,
physicians, pharmacists, nurses, and other mental health professionals.
Independent, unbiased, up-to-date
Packed
with unique, easy-to-read comparison charts and tables (dosages, side
effects, pharmacokinetics, interactions...) for a quick overview of
treatment options
Succinct, bulleted information on all classes
of medication: on- and off-label indications, (US FDA, Health Canada),
recommended dosages, US and Canadian trade names, side effects,
interactions, pharmacodynamics, precautions in the young, the elderly,
and pregnancy, nursing implications, and much more - all you need to
know for each class of drug
Potential interactions and side effects summarized in comparison charts
With instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seek
This
book is a must for everyone who needs an up-to-date, easy-to-use,
comprehensive summary of all the most relevant information about
psychotropic drugs.
New in this edition:
* Antidepressants chapter
revised extensively and includes new sections on the selective serotonin 5-HT1A
agonist gepirone and difficult-to-treat depression
* Antipsychotics chapter
includes a new section on the muscarinic agonist/antagonist combination
(Xanomeline/trospium chloride), a novel treatment that does not block D2 dopamine
receptors. Major revisions to TGA Dosing and Pharmacokinetics
* Drugs for Treatment of
Dementia chapter includes donanemab infusion
* Drugs for ADHD comparison
table expanded
* Drugs of Abuse chapter
has been revised extensively and includes a new section on Psychedelics and
Dissociative Drugs
* New formulations and
trade names include: Abilifi Asimtufii (aripiprazole extended-release 2-monthly
injection), Azstarys (serdexmethylphenidate/dexmethylphenidate capsules),
CAMCEVI (leuprolide 6-month slow-release SC depot injection), Drizalma Sprinkle
(duloxetine capsules), Eldepryl (selegiline tablets and capsules), Esprontia
(topiramate oral solution), Exxua (gepirone extended-release tablets), Ketalar
(ketamine hydrochloride injection), Kisunla (donanemab infusion), Lybalvi
(olanzapine/samidorphan tablets), Onyda (clonidine extended-release
suspension), Relexii (methylphenidate extended-release tablets), Secuado
(asenapine transdermal patch), Zurzuvae (zuranolone capsules)
